FDA 483 - Pharmavite LLC - Opelika - July 25, 2025

Pharmavite LLC - Opelika received a Form FDA 483 following an inspection from July 21-25, 2025. The inspection revealed a significant issue with batch production records, specifically regarding incomplete documentation and premature initialing for critical manufacturing steps. This indicates a lapse in maintaining accurate and complete records for product manufacturing.